Medivis New Augmented Reality Surgical Platform SurgicalAR Receives FDA Approval

New Augmented Reality Surgical Platform Receives FDA Approval

By HospiMedica International Staff Writers

Image: The SurgicalAR platform is a data integration tool that gathers the most relevant patient information and presents it as a 3D model. The rendered 3D model of a patient is mapped back onto the patient, which saves the usual chore of gathering data from all around in order to plan for surgery (Photo courtesy of Medivis).

A new augmented reality (AR) technology platform for surgical applications has received 510(k) clearance for clinical use in the operating room by the US Food and Drug Administration (FDA).

The enterprise SurgicalAR platform developed by medical technology company Medivis (New York, NY, USA) integrates the latest advancements in AR, artificial intelligence (AI), and computer vision to advance surgical visualization, thereby reducing surgical complications and improving patient outcomes while lowering costs for healthcare systems.

(Photo courtesy of Medivis)